Talent
Tackling The Talent Shortfall In Cell And Gene Therapy
The Advanced Therapy Medicinal Products (ATMPs) sector, an area of medicine specialised in gene, tissue and cell therapies, is expanding at an incredibly fast...
Talent in a virtual world – reflections from JP Morgan 2022
In January, I attended the 40th Annual JP Morgan Health Care Conference, the traditional kick off annual event for the global life science investment...
Inspiring Leaders | Dr. Cameron Durrant, MD, DRCOG, MRCGP, MBA
Cameron Durrant, MD, MBA, has served as a member and Chairman of Humanigen’s Board since January 2016, and as the Chief Executive Officer since...
Growing The RSA Group Talent Acquisition team | An interview with Christian Simon
What is your role at RSA and what motivates you to do what you do? I’m head of Talent Acquisition at The RSA Group....
Productive People: how can talent keep pace with emerging pharma manufacturing trends?
New and emerging technologies, such as cell and gene therapies are incredibly exciting, but they are undeniably bringing with them a need for a...
Britain’s talent for technology: Do we have the right skills and capabilities in place to identify and develop the next generation of ATMP’s?
Advanced Therapy Medicinal Products (ATMP’s) offer exciting new opportunities for the treatment of disease and injury. But in such a fast-evolving therapeutic landscape, do...
Inspiring Leaders | Jean-Luc Butel
Jean Luc Butel is an international executive with over thirty years’ experience in the global healthcare industry. He has worked solely for US Fortune...
Recruit, Reward, Retain – training and upskilling in the life sciences
The RSA Group’s Eleanor Davies leads an expert panel discussion at Bio Integrates 2021 Hands up if you’re working in life sciences and want...
Inside the Minds of People at the Cutting Edge of Life Science: How Great Leaders Think
Upcoming Webinar, free to attend We are excited to announce that our first Inspiring Leaders webinar will take place Thursday 13th May at 4pm...
Patrick Hoyle joins The RSA Group as Infrastructure Manager
The RSA Group is delighted to announce that Patrick Hoyle is joining the UK arm of the group as Infrastructure Manager. Patrick has over...
Placement | The RSA Group completes successful search for Fusion Antibodies – Dr Richard Jones appointed as Chief Executive Officer
Following a successful search, The RSA Group is pleased to announce the placement of Dr Richard Jones as Chief Executive Officer at Fusion Antibodies,...
Should people move to jobs or should jobs move to people?
When a talented person is hired by a life sciences organisation, where should they work? This isn’t a story about the pandemic, although undoubtedly...
Inspiring Leaders | Dr. Niven R. Narain
Dr. Niven R. Narain is Co-Founder, President & CEO of Berg, a Boston-based biopharma driving next generation drug and diagnostic development by combining patient-driven...
Claudia Ghilardi joins The RSA Group as an intern
The RSA Group is delighted to announce that Claudia Ghilardi has joined the UK arm of the group as part of its internship programme...
Inspiring Leaders | Prof. Helga Rübsamen-Schaeff
A chemist by training, Professor Helga Rübsamen-Schaeff started her career as Scientific and Executive Director of an academic institution, the Chemotherapeutical Research Institute Georg-Speyer-Haus...
The RSA Group welcomes Heidi Kristiansen as Senior Researcher
The RSA Group, a leading Life Sciences Executive Search firm, is delighted to welcome Heidi Kristiansen to our growing Talent Acquisition Team as a...
Inspiring Leaders | Dr Antonin de Fougerolles
With over 20 years of biotech R&D experience building out drug pipelines and helping drive several multi-billion-dollar companies from start-up, Tony is one of...
What will we need from life sciences leaders in 2021?
As a follow up to my recent blogs, I would like to share some further reflections about what Executive Leaders and Board members in...